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Abstract
Background: Spontaneous preterm delivery (PTD) has a multifactorial etiology with evidence of a genetic
contribution to its pathogenesis. A number of candidate gene case-control studies have been performed on
spontaneous PTD, but the results have been inconsistent, and do not fully assess the role of how two genotypes
can impact outcome. To elucidate this latter point we re-analyzed data from a previously published case-control
candidate gene study, using a case-parent triad design and a hybrid design combining case-parent triads and
control-mother dyads. These methods offer a robust approach to genetic association studies for PTD compared to
traditional case-control designs.
Methods: The study participants were obtained from the Norwegian Mother and Child Cohort Study (MoBa). A total of
196 case triads and 211 control dyads were selected for the analysis. A case-parent triad design as well as a hybrid
design was used to analyze 1,326 SNPs from 159 candidate genes. We compared our results to those from a previous
case-control study on the same samples. Haplotypes were analyzed using a sliding window of three SNPs and a
pathway analysis was performed to gain biological insight into the pathophysiology of preterm delivery.
Results: The most consistent significant fetal gene across all analyses was COL5A2. The functionally similar COL5A1 was
significant when combining fetal and maternal genotypes. PON1 was significant with analytical approaches for single
locus association of fetal genes alone, but was possibly confounded by maternal effects. Focal adhesion (hsa04510), Cell
Communication (hsa01430) and ECM receptor interaction (hsa04512) were the most constant significant pathways.
Conclusion: This study suggests a fetal association of COL5A2 and a combined fetal-maternal association of
COL5A1 with spontaneous PTD. In addition, the pathway analysis implied interactions of genes affecting cell
communication and extracellular matrix.
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Background
Preterm delivery (PTD) is defined as delivery occurring
before 37 weeks of gestation [1]. In Scandinavian coun-
tries PTD rates vary from 5.8% to 6.4% [2]. Children
born preterm are at increased risk of neonatal and
infant mortality and morbidity. Globally, 28% of
neonatal deaths are estimated to be directly attributable
to PTD [3]. PTD can be divided into two main groups
according to clinical presentation: those with sponta-
neous onset with either preterm labor (PTL) or preterm
prelabor rupture of membranes (pPROM) and those
who are delivered due to maternal or fetal complications
(e.g. preeclampsia, small for gestational age) [4].
Spontaneous PTD is a common complex condition
with no single environmental or genetic factor being
completely responsible for its pathogenesis. Known risk
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factors include infection, inflammation, previous PTD,
cigarette smoking, gestational bleeding and low socioe-
conomic status [5]. Four different pathophysiological
pathways have been proposed leading to spontaneous
PTD through a common terminal pathway resulting in
release of uterotonins and proteases that causes cervical
ripening, uterus contractions and membrane rupture [6].
These four pathways are: 1) activation of maternal or
fetal hypothalamic pituitary-adrenal (HPA) axis, 2) local
or systemic inflammation and infection, 3) decidual
hemorrhage and 4) pathological distention of the uterus
[6]. Immunological factors, such as abnormal allograft
reaction and allergy, have also been hypothesized as
possible mechanisms for spontaneous PTD [7]. How
each of these putative causal pathways function has
been difficult to elucidate.
Epidemiological evidence indicates that genetic factors
play a significant role in the etiology of spontaneous
PTD [8-11]. A number of candidate gene studies, almost
exclusively using case-control design, have identified
some genes that associate with PTD [12-17]. However,
the results have rarely been replicated. Of importance
for this phenotype are the possible effects of two gen-
omes, maternal and fetal, and previous studies have
implicated one or the other although epidemiological
data supports the predominance of the maternal gen-
ome. In addition, interactions between maternal and
fetal genomes may affect PTD risk. There has also been
uncertainty about the role of the paternal genome
[8,11,18-20].
In the present study we re-analyzed data from a candi-
date gene case-control study for spontaneous PTD [21]
using a case-parent triad design, which includes infor-
mation from the paternal genome, and a hybrid design
combining case-parent triads and control-mother dyads.
Few studies have used either of these designs for PTD
and none have done so in combination. These
approaches provide several advantages over case-control
designs in terms of minimizing potential population
stratification (case-parent triad design) and their ability
to increase study power (hybrid design) [22,23].
In our study we included the analysis of haplotypes.
Haplotypes are in some cases preferable to SNPs,
because haplotypes can sometimes capture un-geno-
typed functional SNPs better than single SNP analyses
[24]. We considered fetal and maternal effects separately
and in combination. Finally, we examined the distribu-
tion of associating variants based on the KEGG path-
ways in which they exist, to see if particular pathways
are over-represented in our associations, thereby provid-
ing more biological insight that would not be possible
by focusing solely on single genes or SNPs.
Methods
Participants
In a recent case-control candidate genetic association
study, fetal and maternal samples from the Norwegian
Mother and Child Cohort Study (MoBa) were genotyped
at 1,430 SNPs in 140 genes to association with sponta-
neous PTD [21]. In the current study the same data was
used from case and control mother-infant dyads with
the addition of paternal samples from case pregnancies.
The Norwegian Mother and Child Cohort Study (MoBa)
is a pregnancy cohort consisting of more than 107 000
pregnancies recruited from 1999-2008 [25]. The major-
ity of all pregnant women in Norway were invited to
participate through a postal invitation in connection
with routine ultrasound examination at 17-18 weeks of
gestation http://www.fhi.no/morogbarn. The participa-
tion rate was around 44% and a written informed con-
sent was obtained from each participant. The MoBa
study collected biological specimens from mother, father
and offspring and data from questionnaires given to the
mother and father. The study is linked to the Medical
Birth Registry of Norway (MBRN). MBRN receives med-
ical records from every birth that takes place in Norway
after gestational week 16 (after 2002 data is from week
12) [26], and all records from this registry are included
in the MoBa study database. In our analyses we used
samples derived from Version 2 of the MoBa cohort
that included 53,711 pregnancies.
Blood samples were collected from the mother and
father at the ultrasound screening appointment at the
17th-18th week of gestation [27]. A new blood sample
from the mother and a cord blood sample from the
child were drawn at delivery. The majority of samples
were received at the MoBa Biobank the day after collec-
tion and DNA was extracted on the day of receipt as
previously described [27].
Selection of cases and controls has been previously
described [21]. Briefly, cases were defined as live, single-
ton spontaneous PTD between 154 and 258 days of
gestation (220/7-366/7 weeks) in women aged 20 to 34
years. No exclusion criteria were made for the fathers.
Extracted DNA had to be available from the Biobank for
both the mother and child for the family to be included.
Extracted DNA also had to be available for the case
fathers, but not for the controls. Controls were selected
according to the same criteria as cases, except for gesta-
tional age that was between 273 and 286 days (390/7and
406/7 weeks). Two hundred fifteen control dyads were
randomly selected from the eligible dyads. Cases and
controls were not matched on any variables. In Version
2 of the MoBa database we identified 203 case-parent
triads eligible for the study. Among the case-parent
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triads, 9 of the fathers did not have available DNA and
only the case-mother dyads were used.
Candidate genes, SNP selection and genotyping
Selection of candidate genes was based on previous
associations of maternal and fetal genes with sponta-
neous PTD and are described elsewhere [21]. A total of
1,536 SNPs were selected from 143 candidate genes, but
ambiguous placement using the SNPper database http://
snpper.chip.org assigned them to 167 genes; the analyses
were done using this annotation. Genotyping was per-
formed on the Illumina GoldenGate Assay system
http://www.illumina.com/technology/goldengate_genoty-
ping_assay.ilmn.
Data pre-processing
Call-rate, deviations from Hardy-Weinberg equilibrium
(HWE) and Mendelian inconsistencies were determined
with PLINK http://pngu.mgh.harvard.edu/purcell/plink/
[28]. Minor allele frequency (MAF) calculations and
additional analyses were performed using HAPLIN
http://www.uib.no/smis/gjessing/genetics/software/hap-
lin/[22,29,30]. Of the selected SNPs, 1443 SNPs were
successfully genotyped with call-rates greater than 90%.
Of these a total of 31 SNPs on the X-chromosome, 18
SNPs that deviated from HWE (p < 0.01) in controls
and 68 SNPs with a minor allele frequency of < 5%
were excluded from analyses, leaving 1,326 SNPs within
159 genes (Additional file 1 Table S1). Pedigrees
assessed for Mendelian inconsistencies were removed if
more than 1% of the SNPs showed evidence of such;
two case triads and three control dyads were removed
based on this criterion. In addition, families were
excluded if the mother or the offspring had low call-
rates (< 95%). If the father had low call-rate, data from
his DNA was excluded from analysis, but the rest of the
family remained in the study. The final sample size con-
sisted of 407 fetal samples (196 cases, 211 controls), 407
maternal samples (196 cases, 211 controls) and 186
paternal samples (cases only).
Data analysis
The single locus associations and the haplotype analyses
were performed using HAPLIN software. Haplin can
analyze case-parent triad data, case-control data and
hybrid designs combining data from both case triads
and control triads. It uses a full likelihood model, and
estimates both population frequencies and relative risks
relating to each haplotype [29]. The case-parent triad
design has advantages and disadvantages relative to the
case-control design [31]. For example, population-based
case-control designs may be affected by population stra-
tification, while family-based designs are robust to this
[31]. Case-parent triad analyses and hybrid analyses also
make it possible to better evaluate the balance of mater-
nal and fetal effects. This is a substantial advantage for
phenotypes that have their origins in fetal life and there-
fore can be influenced by both maternal genetics and
the intra-uterine environment [32]. Simply comparing
case mothers with control mothers or case children with
control children does not account for differential effects
of maternal and fetal genotypes. Triad analysis assumes
mating symmetry in the population at large, and esti-
mates the effects of maternal and fetal genes simulta-
neously. However, case-parent triad analyses have
slightly less power than case-control studies and cannot
estimate exposure effects [31]. The hybrid design com-
bines case-parent triads and control-mother dyads in a
joint likelihood model, and thus has a higher power
than the case-parent triad and the case-control designs
used separately [23,33]. Hybrid analyses may, however,
still be vulnerable to the effects of population stratifica-
tion, though less so than the case-control design [23].
Therefore, we have re-analyzed data from a previous
study to assess if: 1) we find evidence for association in
the same genes as previously reports, and 2) if new
genes can be detected using this family based analysis
plan.
SNPs and haplotypes were analyzed using the case-
parent triad design and a hybrid design combining
case-parent triads and control-mother dyads. The ana-
lyses were done both by looking at the effect of the
fetal genes alone and by combining the effects of fetal
and maternal alleles to avoid confounding by maternal
genes [34]. In the combined estimation model, separate
relative risks for fetal and maternal effects are esti-
mated simultaneously in a joint model, adjusted for
each other. The combined p-value refers to a likeli-
hood ratio test comparing a full model including fetal
to maternal effects with a null model with no effects
whatsoever. In addition, we performed Wald tests to
assess whether a second genome contributed signifi-
cantly to PTD relative to only a single genetic
contribution.
In addition to calculating p-values for individual SNPs,
haplotypes were analyzed using overlapping sliding-win-
dows of three SNPs. Haplotype significance and effect
sizes were calculated relative to the most frequent hap-
lotype. A multiplicative gene-dose model was assumed.
To control for multiple testing within a gene, a single
overall p-value was computed for each gene, using a
score test procedure in Haplin [35]. To assess the effect
of multiple testing as a whole, QQ-plots were used to
plot the observed p-values against p-values expected
purely by chance, i.e., p-values drawn from a uniform
distribution.
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Pathway analyses were performed using R http://www.
r-project.org/[36]. The pathway analysis aimed at identi-
fying pathways whose genes taken together are more
associated with disease than random candidate genes
from our study. That is, the criterion for significance of
a pathway is that it has more genes associating with
PTD than the “background” effects from our candidate
genes as opposed to an a priori statistical distribution.
This is a more conservative than the null hypothesis of
no effects of any of the included genes. Pathways were
analyzed using results of case-parent triads and a hybrid
design using both case-parent triads and control-mother
dyads. The analyses were done using fetal SNPs alone as
well as using a combined estimate of fetal and maternal
SNPs. Adjusted p-values for genes were matched to
respective KEGG pathways using the KEGG_2_snp_b129
annotation http://www.genome.jp/kegg/[37]. Combined
pathway-specific p-values were then obtained using a
Fisher combination of p-values. That is, the combined
p-value for a pathway is computed from a Chi-squared
distribution with 2 k degrees of freedom, using -2(log
(p1) +... +log(pk)) as the test statistic, where k is the
number of genes in the pathway and pi is the p-value
for gene in the pathway. The Fisher combination of p-
values assumes independence between genes within the
same pathway, which may not strictly be the case. We
performed 10,000 simulations where the test statistic for
a pathway was compared to the simulated test statistics
obtained from drawing genes randomly from our study,
each time selecting the same number of genes as found
in the specific pathway. The resulting simulated pathway
p-values were practically identical to the Fisher chi-
squared values. In total 212 pathways were assessed
(Additional file 2 Table S2).
Ethics approval
Approval for this study was obtained from the Regional
Committee for Medical Research and Ethics (S-06075)
and the Norwegian Data Inspectorate (05/016784).
Results
As expected from the case definition, cases and controls
differed with respect to gestational age and birth weight
(Table 1). In addition, there were significantly more pri-
miparous women and women with a previous PTD in
the case group than in the control group (Table 1). No
other demographic differences existed between cases
and controls.
Analysis of fetal genes
Significant associations were observed in the fetal ana-
lyses. The most significant gene in the case-parent triad
approach was COL5A2 (collagen V alpha-2) with p =
0.006 in the single locus analysis and p = 0.002 in the
haplotype analysis (Table 2 Figure 1). This gene was
also significant in the hybrid analysis (Table 2 Figure 1).
Within this gene several SNPs showed evidence of asso-
ciation (Table 3 and 4), as were several haplotypes
(Table 5 and 6).
The most significant single locus association was with
the G allele at rs7420331. This SNP had a p-value of
0.001 with a relative risk (RR) of 0.47 (confidence inter-
val, (CI): 0.30, 0.73) in the case-parent triad analysis and
a p-value of 0.004 and a RR of 0.53 (CI: 0.35, 0.85) in
the hybrid analysis, indicating that the G allele protects
against spontaneous PTD. The single locus association,
rs7420331, also had a significant uncorrected genotypic
result in the previous case-control study (p = 0.01) [21].
The other three SNPs in COL5A2 had a p-value of
0.021 and an RR of 2.29 (CI: 1.12, 4.54) in the case-par-
ent triad analysis. In the hybrid analysis the p-value was
0.015 with an RR of 1.95 (CI: 1.14, 3.31). This indicates
that these SNPs associate with increased risk of sponta-
neous PTD, but since they are in strong linkage disequi-
librium with each other they cannot be considered
independently and most likely tag a single causal variant.
In the hybrid analysis the most significant gene was
TFPI (tissue factor pathway inhibitor), which also was
the most significant fetal gene in the previous case-con-
trol study on the same samples [21]. However, this gene
was not significant in the case-parent triad analysis,
except for one SNP at rs6434222. PON1 (paraoxonase
1) was significant using all analytical approaches, except
for the haplotype analysis in the case-parent triad design
where it was borderline significant (p = 0.053) (Table 2).
Moreover, this gene was found to be significant in fetal
samples in the previous published case-control analysis
[21]. The most significant SNP in this gene was
rs854552 for all three approaches, with the G allele con-
ferring a protective effect against PTD (p = 0.001 in the
case-parent triad analysis and p = 0.0003 in the hybrid
analysis).
The three haplotypes in COL5A2 that were the most
significant were equivalent in their association with
PTD: G-A-G at rs6434322-rs10165260-rs7420331 (p =
0.001) with an RR of 0.49 (CI: 0.31, 0.77), A-A-G at
rs3923384-rs6434317-rs6434322 (RR = 0.49, CI: 0.31,
0.77) and A-G-A at rs6434317-rs6434322-rs10165260
(RR = 0.49, CI: 0.31, 0.77) (Table 7). This indicates that
they tag the same associating variant(s).
Combined analysis of fetal and maternal genes
When including maternal effects COL5A2 remained sig-
nificant in all analyses except the hybrid single locus
approach, which was borderline (p = 0.059) (Table 7
Figure 2). In addition a related gene, COL5A1 (collagen
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V alpha-1), was significant in the single locus analysis
both in the case-parent triad approach and in the hybrid
approach. When looking at maternal and fetal SNPs in
COL5A2 separately (Table 3 and 4), it is evident that
the SNPs were significant only for the fetal genotypes,
but not the maternal. The combined effect of the fetal
and the maternal genotypes is less significant than the
fetal gene, indicating that the association with this gene
is driven by the fetal genome. The same was true for
the haplotypes (Table 5 and 6). COL5A1 on the other
hand, showed significance for both fetal and maternal
genotypes, but the overall p-value for the gene did not
reach significance when considering fetal SNPs alone.
When looking at the significant fetal and maternal SNPs
in COL5A1 separately and combined it becomes clear
that the combined effect for several of the fetal and
maternal SNPs are stronger than when considered sepa-
rately. This implies a combined effect of fetal and
maternal alleles. In the case-control analysis [21] one
fetal SNP in COL5A2 (rs7420331) and one in COL5A1
were significant in the uncorrected analysis. In the
maternal samples, five SNPs were significant in
COL5A1. The most significant gene in the hybrid single
locus analysis was TFPI (tissue factor plasminogen inhi-
bitor) (Table 2, 5 and 6). In the haplotype analysis the
most significant genes were SLC23A1 (Solute carrier
family 23 member 1) for the case-parent triad approach
and MMP8 (matrix metalloproteinase 8) for the hybrid
approach (Table 2).
Pathway analysis
We identified several pathways as significantly associat-
ing with spontaneous PTD. The most significant fetal
pathways were Focal Adhesion (hsa04510), p53 signaling
(hsa04115), Cell Communication (hsa01430), and ECM
(extracellular matrix) receptor interaction (hsa04512)
(Table 8). Looking at the combined effect of maternal
and fetal SNPs the most significant pathways were Glu-
tathione metabolism (hsa00480) and Prostate Cancer
(hsa05215) (Table 9). Cell Communication, ECM-recep-
tor interaction and Focal Adhesion remained significant
when including maternal effects.
Discussion
In the present study we presented a re-analysis of pre-
viously published data that further elucidated the
Table 1 Clinical and demographical characteristics
Cases (n = 196) Controls (n = 211) p
Maternal age (years) 29 [20-34] 30 [21-34] 0.135
Gestational age (days) 253 [172-258] 280 [273-286] < 0.001
Primiparity 128 (65.3%) 98 (46.4%) < 0.001
Smoking wk 1-17 of pregnancy (%) 64 (32.7%) 55 (26.1%) 0.124
Pre-pregnancy BMI 23.03 [14.84-41.26] 23.23 [17.30-38.10] 0.561
Birth weight (g) 2815 [747-4000] 3645 [2610-4970] < 0.001
Gender infant, male 51.5% 42.7% 0.073
Paternal age (years) 31 [20-46] 31 [23-48] 0.561
Previous PTD 18 (9.2%) 3 (1.4%) < 0.001
Gestational bleeding, 2nd trimester 28 (15.8%) 21 (10.9%) 0.161
1 Medians are reported with the range in brackets.
2 Cases are defined as preterm delivery < 37 weeks of gestation, while controls are defined as term delivery from 39+0 to 40+6 weeks of gestation.
3 P-values are calculated by Mann-Whitney U test for continuous variables and chi-square test for categorical variables.
4 Information about pre-pregnancy BMI and smoking in week 1-17 of pregnancy is self reported and collected from MoBa Questionnaire 1.
Table 2 Significant fetal genes
Case-parent triad design Hybrid design
Single locus Haplotype Single locus Haplotype
COL5A2 0.006 0.002 0.034 0.013
PLG 0.010 0.014 0.336 0.530
IGFBP3 0.011 - 0.091 -
PON1 0.022 0.053 0.005 0.021
G0S2 0.028 - 0.007 -
AKAP5 0.032 - 0.036 -
PTCRA 0.061 0.042 0.098 0.112
IL1A 0.064 0.090 0.014 0.018
SMCR8 0.084 - 0.040 -
SLC23A1 0.091 0.032 0.336 0.091
TCN2 0.130 - 0.036 -
TFPI 0.131 0.317 0.001 0.005
IL4 0.150 0.186 0.047 0.045
DEFA3 0.152 0.047 0.146 0.070
CRH 0.157 0.269 0.072 0.031
IL10RB 0.275 0.193 0.156 0.006
NAT1 0.285 0.032 0.546 0.118
MMP8 0.319 0.278 0.216 0.046
CD14 0.328 0.049 0.616 0.309
TREM1 0.387 0.224 0.189 0.039
TNFRSF1B 0.770 0.045 0.458 0.161
IL4R 0.814 0.277 0.079 0.020
1 Correction for multiple testing has been performed within each gene.
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relative roles of maternal and fetal genomes on spon-
taneous PTD. In the previous study that used overlap-
ping data, the most significantly associated genes were
COL1A2 and PTGER3 in the maternal and TFPI and
PON1 in the fetal analyses. We confirmed in our ana-
lyses an association with PON1. However, TFPI,
which was found in the previous study, was only sig-
nificant in our hybrid analysis. It is likely that the
original finding was due to population stratification, a
factor minimized by the family based analyses we
used.
Using our approach, the most consistent significant
gene across all analyses was COL5A2, which is
involved in the production of type V collagen. The
previous analysis only provided minimal evidence for
the association with this gene [21]. COL5A1, which
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Figure 1 Fetal results. QQ-plots showing the most significant fetal genes for the different designs. A) Single locus, case-parent triad. B)
Haplotype, case-parent triad. C) Single locus, hybrid. D) Haplotype, hybrid. The observed p-values for each gene are plotted against the
expected p-values. If there is no effect of the genes, the p-values will be positioned on the straight line. The grey area along the straight line
shows the point-wise confidence interval for the expected p-values. Correction for multiple testing was performed within each gene. There have
been done no adjustments for covariates in the hybrid analysis.
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also contributes to the production of type V collagen,
was also found to be significant in the single locus
analysis when maternal effects were included, and sev-
eral SNPs were significant when examining maternal
and fetal alleles separately (Table 5 and 6). Type V
collagen plays a critical role in early fibril initiation
and in the determination of fibril structure and matrix
organization [38]. Defects in type V collagen due to
mutations in COL5A1 and COL5A2 are the cause of
the classical type (types I and II) of the heritable con-
nective tissue disorder Ehler-Danlos syndrome that
confers an increased risk for PTD if the fetus is
affected, especially from pPROM [39-41]. It is there-
fore reasonable to hypothesize that variations in these
genes might be involved in the pathophysiology lead-
ing to PTD. However, the results must be interpreted
with care, as the QQ-plots shows that the observed p-
values do not deviate from what would be expected by
chance. Few other studies have tested the association
between COL5A2 and the risk of spontaneous PTD. A
recent study by Romero et al found an association
between rs189683203 in fetal DNA and the risk of
pPROM with an unadjusted p-value of 0.021 (odds
ratio, (OR) = 1.42, CI: 1.06, 1.92) [17]. In another
Table 3 Significant SNPs in COL5A2 (collagen V alpha-2) and COL5A1 (collagen V alpha-1)
Fetal Maternal Combined
gene snp allele MAF RR 95% CI p RR 95% CI p overall p
COL5A2 rs3923384 G 0.034 2.29 1.12, 4.54 0.021 0.83 0.43, 1.59 0.568 0.048
rs6434322 A 0.034 2.29 1.12, 4.54 0.021 0.83 0.43, 1.59 0.568 0.048
rs10165260 G 0.034 2.29 1.12, 4.54 0.021 0.83 0.43, 1.59 0.568 0.048
rs7420331 G 0.154 0.47 0.30, 0.73 0.001 1.09 0.70, 1.69 0.710 0.003
COL5A1 rs4842161 C 0.482 1.32 0.99, 1.75 0.060 0.75 0.57, 1.00 0.055 0.024
rs3124932 A 0.433 1.53 1.14, 2.03 0.005 0.78 0.58, 1.04 0.084 0.003
rs12005720 G 0.137 0.83 0.56, 1.22 0.343 1.61 1.08, 2.40 0.018 0.034
rs3128621 A 0.440 1.49 1.12, 1.99 0.008 0.70 0.53, 0.93 0.015 0.001
rs4842167 G 0.388 1.51 1.13, 2.03 0.007 0.70 0.52, 0.93 0.016 0.001
rs3811161 G 0.509 0.70 0.52, 0.93 0.012 1.32 0.99, 1.75 0.060 0.007
rs3811152 G 0.092 0.59 0.36, 0.95 0.032 1.72 1.05, 2.79 0.031 0.008
rs10745387 A 0.405 1.36 1.02, 1.82 0.037 0.75 0.56, 1.00 0.055 0.016
Case-parent triad analysis
1 Results are not corrected for multiple testing.
2 A multiplicative model is assumed.
Table 4 Significant SNPs in COL5A2 (collagen V alpha-2) and COL5A1 (collagen V alpha-1)
Fetal Maternal Combined
gene snp allele MAF RR 95% CI p RR 95% CI p overall p
COL5A2 rs3923384 G 0.042 1.95 1.14,3.31 0.015 0.76 0.42, 1.35 0.347 0.055
rs6434322 A 0.042 1.94 1.14,3.31 0.013 0.76 0.42, 1.35 0.342 0.055
rs10165260 G 0.042 1.95 1.14,3.31 0.015 0.76 0.42, 1.35 0.347 0.055
rs7420331 G 0.129 0.53 0.35,0.81 0.004 1.28 0.87, 1.85 0.199 0.008
COL5A1 rs3124311 C 0.510 0.77 0.60, 0.99 0.045 1.06 0.83, 1.37 0.624 0.130
rs4842157 G 0.364 0.75 0.57, 0.99 0.039 1.07 0.81, 1.39 0.631 0.115
rs4842161 C 0.458 1.40 1.10, 1.80 0.008 0.81 0.63, 1.03 0.085 0.017
rs3124932 A 0.433 1.52 1.19, 1.96 0.0004 0.78 0.61, 1.00 0.054 0.002
rs12005720 G 0.161 0.74 0.53, 1.04 0.090 1.40 1.01, 1.94 0.043 0.063
rs3128621 A 0.441 1.48 1.16, 1.90 0.001 0.70 0.54, 0.90 0.006 0.001
rs4842167 G 0.424 1.37 1.07, 1.76 0.014 0.64 0.49, 0.82 0.001 0.001
rs3811161 G 0.465 0.78 0.61, 1.00 0.055 1.49 1.16, 1.90 0.003 0.004
rs3811152 G 0.103 0.55 0.35, 0.86 0.009 1.54 1.04, 2.27 0.033 0.009
rs10745387 A 0.434 1.25 0.98, 1,61 0.073 0.70 0.54, 0.90 0.005 0.011
Hybrid analysis
1 Results are not corrected for multiple testing.
2 A multiplicative model is assumed.
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study on the same study population the authors found
an association between rs6750027 in maternal DNA
and the risk of PTL with an unadjusted p-value of
0.043 (OR = 1.32, CI: 1.01, 1.74) [13]. Another study
by Velez et al found significant associations in three
fetal SNPs and one maternal SNP in COL5A2 [12].
PON1 was significantly associated with PTD in both
the triad analysis and the hybrid analysis of the fetal
genes alone, but not in the combined analysis of
maternal and fetal genes. This is most likely because
the combined effects of maternal and fetal genes may
not reach significance due to reduced power in this
type of analysis. None of the maternal SNPs showed
an association with spontaneous PTD, while several of
the fetal SNPs did. PON1 was found to be signifi-
cantly associated with PTD in the previously pub-
lished case-control analysis on the same fetal samples
as well, and possible mechanisms of how this gene
might contribute to preterm delivery are discussed
there [21].
TFPI which was the strongest fetal association in the
case-control study [21], showed at best weak associa-
tion in the triad-analysis, but was the most significant
gene in the hybrid design. The most significant SNP in
the case-control study, rs6434222 in TFPI, also had a
significant unadjusted p-value in the triad analysis (p =
0.02).
Overall, the results from the case-parent-triad ana-
lysis and the previously performed case-control analy-
sis only overlapped in a few genes. The results from
the hybrid analysis lay somewhere in-between the
results from the case-parent triad and the case-con-
trol study. These differences may indicate that within
our study population there was population stratifica-
tion that could have led to spurious results in the
case-control analysis. This is minimized using triads.
Although the hybrid analysis has more power than
the triad analysis, it may still be affected by popula-
tion stratification, but to a lesser degree than a case-
control design. The case-parent triad analysis is there-
fore the most reliable in terms of reducing the pro-
blem of stratification, and we present these as our
most compelling results.
Our study also identified several pathways as asso-
ciating with PTD. Significant results were found in the
Focal Adhesion, Cell Communication and ECM-recep-
tor interaction pathways, all of which include COL5A2
and COL5A1, but none of the other associated genes
Table 5 Fetal and maternal haplotypes in COL5A2
Fetal haplotypes Maternal haplotypes Combined
Markers Haplotype freq RR 95% CI p RR 95% CI p Overall p
rs6760780-rs3923384-rs6434317 T-A-C 0.810 1.00 - - 1.00 - - 0.006
T-A-A 0.116 0.55 0.33, 0.92 0.021 0.97 0.59, 1.60 0.920
A-A-A 0.035 0.33 0.13, 0.85 0.020 1.50 0.64, 3.50 0.351
A-G-A1 0.034 2.11 1.05, 4.22 0.035 0.84 0.44, 1.60 0.594
rs3923384-rs6434317-rs6434322 A-C-G 0.810 1.00 - - 1.00 - - 0.003
A-A-G1 0.154 0.49 0.31, 0.77 0.002 1.08 0.70, 1.67 0.724
G-A-A 0.034 2.09 1.03, 4.19 0.042 0.83 0.44, 1.60 0.588
rs6434317-rs6434322-rs10165260 C-G-A 0.810 1.00 - - 1.00 - - 0.003
A-G-A1 0.154 0.49 0.31, 0.76 0.002 1.07 0.69, 1.65 0.747
A-A-G 0.034 2.09 1.03, 4.18 0.040 0.83 0.43, 1.60 0.584
rs6434322-rs10165260-rs7420331 G-A-A 0.810 1.00 - - 1.00 - - 0.003
G-A-G 0.154 0.49 0.31, 0.77 0.001 1.08 0.70, 1.67 0.726
A-G-A 0.035 2.09 1.03, 4.19 0.041 0.83 0.44, 1.61 0.592
rs10165260-rs7420331-rs13024858 A-A-A 0.762 1.00 - - 1.00 - - 0.010
A-G-A 0.149 0.50 0.31, 0.79 0.003 1.00 0.64, 1.58 0.993
A-A-C 0.047 1.20 0.58, 2.44 0.631 0.57 0.27, 1.20 0.138
G-A-A 0.028 1.74 0.72, 4,24 0.211 0.50 0.21, 1.19 0.122
G-A-C 0.008 2.37 0.71, 7.54 0.151 1.70 0.56, 5.11 0.343
rs7420331-rs13024858-rs6752781 A-A-A 0.794 1.00 - - 1.00 - - 0.016
C-A-A 0.151 0.48 0.30, 0.77 0.002 1.03 0.65, 1.60 0.913
A-C-G 0.053 1.43 0.77, 2.63 0.259 0.81 0.44, 1.48 0.492
Case-parent triad analysis
1 Haplotype deviates from Hardy-Weinberg equilibrium.
2 Calculation of haplotypes has been performed in Haplin with a sliding window of three SNPs.
3 Haplotypes are not adjusted for multiple testing.
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in our study. The ECM-receptor interaction pathway
is involved in tissue and organ morphogenesis asso-
ciated with the bleeding disorders Bernard-Soulier
syndrome and Glanzmann thrombasthenia. The Focal
adhesion pathway is involved in cell matrix adhesion
and also associated with the bleeding disorder Glanz-
mann thrombasthenia. For the Notch signaling
(hsa04330), Gluthatione Metabolism (hsa00480) and
Glyoxylate and dicarboxylate metabolism (hsa00630)
pathways only one gene was available for inclusion
and the results from these pathways must be inter-
preted with care. Because this was a candidate gene
study, the number of included genes and SNPs in
each pathway was limited. Nevertheless, those path-
ways that provide strong evidence of association can
probably be taken as truly being involved in sponta-
neous PTD.
The major strength of this study was that we used the
case-parent triad design and the hybrid design and com-
pared these results to those of the traditional case-con-
trol design. Few other candidate gene studies on PTD
have been performed using the case-triad design, which
offers protection against bias due to population
Table 6 Fetal and maternal haplotypes in COL5A2
Fetal haplotypes Maternal haplotypes Combined
markers haplotype freq RR 95% CI p RR 95% CI p Overall p
rs6760780-rs3923384-rs6434317 T-A-C 0.830 1.00 - - 1.00 - - 0.013
T-A-A 0.091 0.65 0.41, 1.05 0.077 1.20 0.77, 1.86 0.419
A-G-A 0.041 1.82 1.06, 3.08 0.030 0.78 0.44, 1.41 0.413
A-A-A 0.037 0.33 0.14, 0.81 0.014 1.48 0.76, 2.88 0.244
rs3923384-rs6434317-rs6434322 A-C-G 0.828 1.00 - - 1.00 - - 0.006
A-A-G 0.129 0.54 0.36, 0.82 0.004 1.26 0.87, 1.84 0.241
G-A-A 0.042 1.81 1.06, 3.10 0.029 0.78 0.43, 1.39 0.393
rs6434317-rs6434322-rs10165260 C-G-A 0.829 1.00 - - 1.00 - - 0.006
A-G-A 0.129 0.55 0.36, 0.83 0.006 1.27 0.88, 1.84 0.210
A-A-G 0.042 1.81 1.06, 3.10 0.026 0.77 0.43, 1.40 0.385
rs6434322-rs10165260-rs7420331 G-A-A 0.829 1.00 - - 1.00 - - 0.006
G-A-G 0.129 0.54 0.36, 0.82 0.004 1.26 0.87, 1.83 0.232
A-G-A 0.042 1.80 1.06, 3.11 0.026 0.78 0.43, 1.39 0.392
rs10165260-rs7420331-rs13024858 A-A-A 0.792 1.00 - - 1.00 - - 0.041
A-G-A 0.109 0.58 0.37, 0.91 0.018 1.33 0.90, 1.97 0.159
A-A-C 0.035 1.46 0.78, 2.76 0.242 0.70 0.35, 1.44 0.329
G-A-A 0.022 2.23 1.12, 4.57 0.023 0.63 0.28, 1.40 0.262
A-G-C 0.020 0.38 0.10, 1.55 0.175 0.72 0.23, 2.29 0.582
G-A-C 0.019 1.44 0.65, 3.20 0.362 0.95 0.42, 2.23 0.901
rs7420331-rs13024858-rs6752781 A-A-A 0.817 1.00 - - 1.00 - - 0.043
G-A-A 0.109 0.55 0.35, 0.86 0.009 1.37 0.92, 2.05 0.116
A-C-G 0.053 1.41 0.86, 2.38 0.187 0.83 0.48, 1.42 0.516
G-C-G 0.020 0.47 0.13, 1.81 0.277 0.70 0.22, 2.22 0.542
Hybrid analysis
1 Calculation of haplotypes has been performed in Haplin with a sliding window of three SNPs.
2 Haplotypes are not adjusted for multiple testing.
Table 7 Significant genes when maternal and fetal alleles
are combined
Case-parent triad design Hybrid design
Single locus Haplotype Single locus Haplotype
IGFBP3 0.010 - 0.216 -
GSTP1 0.014 - 0.016 -
COL5A1 0.018 0.104 0.014 0.077
COL5A2 0.022 0.016 0.059 0.031
MTHFD1 0.023 0.051 0.048 0.116
PLG 0.025 0.049 0.121 0.144
MMP8 0.034 0.073 0.041 0.008
IL10RA 0.050 0.028 0.083 0.044
SLC23A1 0.066 0.007 0.549 0.215
PON1 0.082 0.131 0.025 0.120
G0S2 0.085 - 0.022 -
IL1A 0.187 0.276 0.048 0.085
TFPI 0.304 0.599 0.004 0.039
SERPINH1 0.354 0.088 0.216 0.016
TREM1 0.459 0.268 0.106 0.041
SLC6A4 0.525 0.346 0.032 0.045
HSPA6 0.583 0.310 0.050 0.182
IL10RB 0.618 0.584 0.406 0.031
1 Correction for multiple testing has been performed within each gene.
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stratification. Additionally, we performed a hybrid analy-
sis, which has increased statistical power over both the
case-triad and the case-control designs. These designs
also provide separate estimates of fetal and maternal
alleles, as well as an overall p-value estimating the com-
bined effect of maternal and fetal alleles. In this way,
confounding through maternal alleles, which can affect
the intrauterine environment and thus the phenotype of
the fetus, can be avoided. Our study was limited in that
the small sample size was small compared to modern
GWAS level analyses and in that it was based on a lim-
ited number of candidate genes. Also, no covariates
were included in the hybrid analysis and we were not
able to separate spontaneous PTD into pPROM and
PTL at the time of analysis. Another weakness of this
study is that we did not have an external replication
sample to corroborate our findings. The findings should
thus be regarded as exploratory, although the prior plau-
sibility of the genes provides increased confidence in our
results.
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Figure 2 Combined results for fetal and maternal genes. QQ-plots showing the most significant results for the different designs when the
effects of maternal and fetal genes are combined. A) Single locus, case-parent triad. B) Haplotype, case-parent triad. C) Single locus, hybrid. D)
Haplotype, hybrid.
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Conclusion
The results from this study suggest that fetal SNPs and
haplotypes in COL5A2 and a combined effect of fetal
and maternal SNPs in COL5A1 are associated with
spontaneous PTD. The significant pathways, Focal adhe-
sion, Cell communication and ECM receptor interaction
all included COL5A2 and COL5A1.
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